Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCCRE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,718
Award facts
- Contract value 100% obligated
- $17,718.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $17,718.33. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains the comprehensive SPE2DX prime IDV valued at $999,999,999.00 through December 2026, which supports military healthcare systems globally.
This delivery order exemplifies AmerisourceBergen's role in supplying pharmaceutical products to the Department of Defense medical supply chain. Eliquis (apixaban) is an anticoagulant medication widely used in military and veteran healthcare systems. The contract fulfills immediate pharmaceutical needs through the company's established framework agreement, enabling rapid delivery of essential medications to support defense health operations. AmerisourceBergen's federal contract portfolio demonstrates its consistent capability to deliver medications across multiple therapeutic domains, from specialty pharmaceuticals to generic drugs, reinforcing its position as a primary vendor for DLA's pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FCCRE?
SPE2DB25FCCRE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FCCRE worth?
The government has obligated $17,718 on SPE2DB25FCCRE.
Is contract SPE2DB25FCCRE an order under another contract?
Yes. SPE2DB25FCCRE is a delivery order under SPE2DB24D1007, an indefinite delivery contract.
Was contract SPE2DB25FCCRE competed?
The extent of competition for SPE2DB25FCCRE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award